Moleculin 公布2026年第一季度财务业绩并通报关键性Miracle试验临床进展

美股速递
May 15

Moleculin Biotech, Inc. 已公布其2026年第一季度的财务业绩,并同步提供了关于其关键性Miracle试验的最新临床进展。 公司报告了本季度的财务状况,同时详细阐述了其核心临床试验项目的当前状态与未来规划。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10